An Open-Label Phase 1 Study of Ceralasertib in Japanese Patients with Advanced Solid Malignancies

Trial Identifier: D5330C00014
Sponsor: AstraZeneca
Start Date: June 2022
Primary Completion Date: August 2023
Study Completion Date: March 2024
Condition: Cancer - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version
Japanese Translation

Trial Locations

Country Location
JP Chuo-ku, JP, 104-0045